NCT04539327
Who may be able to join
Who might be able to join this trial:
- You must be willing to sign a consent form if you are able to be contacted and are alive (in some cases, consent may not be needed for patients who cannot be reached, depending on legal and ethical rules in Spain)
- You must have been diagnosed with a specific type of cancer — high-grade ovarian cancer, fallopian tube cancer, or primary peritoneal cancer — confirmed by a tissue sample (biopsy), and must have been treated through a special medication access program in Spain called the Rucaparib Access Program (RAP)
- You must be a woman who was 18 years old or older at the time of your diagnosis
Who may not be able to join:
- You would not be eligible if your medical records are unavailable, missing, incomplete, or cannot be retrieved
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants With Relevant Co-morbidities; Other Previous Cancers?; Family History of Cancers?; FIGO STAGE; Tumor Histology; BCRA Status; Deficiencies in Other Genes Involved in Homologous Recombination; Surgeries Before Rucaparib; Previous Lines; PARPi Before Rucaparib; Average Dose of Rucaparib Received Per 12 Hours; Rucaparib Drug Exposure; Dose Reductions; Number of Dose Interruptions; Duration of Response (DoR); End of Treatment; Objective Response Rate (ORR); Progression-free Survival (PFS); Radiological Best Overall Response; Biological Best Overall Response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.